Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study*
Pietro Quaglino, H. Miles Prince, Richard Cowan, et al.
British Journal of Dermatology (2020) Vol. 184, Iss. 4, pp. 722-730
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
Johanna Latzka, Chalid Assaf, M. Bagot, et al.
European Journal of Cancer (2023) Vol. 195, pp. 113343-113343
Open Access | Times Cited: 68
Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2022) Vol. 98, Iss. 1, pp. 193-209
Open Access | Times Cited: 51
Quality of life in patients with Mycosis Fungoides and Sézary Syndrome: a systematic review of the literature
Rosanne Ottevanger, Sylvia van Beugen, Andrea W.M. Evers, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 35, Iss. 12, pp. 2377-2387
Open Access | Times Cited: 39
Cutaneous T‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2021) Vol. 96, Iss. 10, pp. 1313-1328
Open Access | Times Cited: 38
International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies
Belinda A. Campbell, Gábor Dobos, Zahra Haider, et al.
Blood Advances (2023) Vol. 7, Iss. 21, pp. 6639-6647
Open Access | Times Cited: 16
Cutaneous B‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2020) Vol. 95, Iss. 10, pp. 1209-1213
Open Access | Times Cited: 39
Health‐related quality of life and its influencing factors in patients with primary cutaneous B‐cell lymphomas: A multicentric study in 100 patients
A. E. C. Schirren, John D. Albrecht, Susanne Melchers, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 5, pp. 954-966
Open Access | Times Cited: 4
The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets
Alba Guglielmo, Corrado Zengarini, Claudio Agostinelli, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 584-584
Open Access | Times Cited: 4
Identification of subgroups of early-stage mycosis fungoides patients with increased itch and impaired quality of life
Julia Nenonen, Anna H. Winther, Pontus Jonsson, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Overall and Cause‐Specific Mortality Among Patients With Cutaneous T‐Cell Lymphoma in the United States
Lauren Shea, Mayur Narkhede, Karthik Chamarti, et al.
eJHaem (2025) Vol. 6, Iss. 2
Open Access
Clinical Characteristics, Management and Long‐Term Outcomes of 180 Patients With Early‐Stage Mycosis Fungoides at a Tertiary Centre—A 34‐Year Retrospective Study
Banu İsmail Mendi, İncilay Kalay Yıldızhan, Hatice Şanlı
Australasian Journal of Dermatology (2025)
Closed Access
Histopathologic Evaluation of Density and Depth of the Lymphoid Infiltrate in Clinically Defined Patches and Plaques in Early Stage Mycosis Fungoides
Juliette M. Kersten, Rosanne Ottevanger, Thom Doeleman, et al.
Journal of Cutaneous Pathology (2025)
Open Access
Folliculotropic Mycosis Fungoides: Current Guidance and Experience from Clinical Practice
Gabriele Roccuzzo, Luca Mastorino, Giuseppe Gallo, et al.
Clinical Cosmetic and Investigational Dermatology (2022) Vol. Volume 15, pp. 1899-1907
Open Access | Times Cited: 17
Radiotherapy in Cutaneous Lymphomas: Recommendations from the EORTC Cutaneous Lymphoma Tumour Group
Khaled Elsayad, Emmanuella Guenova, Chalid Assaf, et al.
European Journal of Cancer (2024) Vol. 212, pp. 115064-115064
Closed Access | Times Cited: 3
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion
Emmilia Hodak, Larisa J. Geskin, Emmanuella Guenova, et al.
American Journal of Clinical Dermatology (2022) Vol. 24, Iss. 1, pp. 5-14
Open Access | Times Cited: 16
Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC‐CLTG/ISCL survey
Pietro Quaglino, Julia Scarisbrick, Gabriele Roccuzzo, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 4, pp. 680-688
Open Access | Times Cited: 9
Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources
Mona Abdel-Halim Ibrahim, Nada Eltayeb, Mirna Michel Ibrahim, et al.
Dermatology Research and Practice (2023) Vol. 2023, pp. 1-16
Open Access | Times Cited: 7
Involvement of cutavirus in a subset of patients with cutaneous T-cell lymphoma with an unfavorable outcome
Yumiko Hashida, Kimiko Nakajima, Tomonori Higuchi, et al.
Journal of Clinical Virology (2023) Vol. 165, pp. 105523-105523
Open Access | Times Cited: 7
Psychological Distress and Treatment Outcome in Patients With Early-Stage Mycosis Fungoides
Meagan‐Helen Henderson Berg, Gizelle Popradi, David Roberge, et al.
Journal of Cutaneous Medicine and Surgery (2024) Vol. 28, Iss. 1, pp. 29-32
Open Access | Times Cited: 2
Advances in the pharmacological management of cutaneous T-cell lymphoma
Gabriele Roccuzzo, A Roggo, Egle Ramelyte, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 7, pp. 885-894
Closed Access | Times Cited: 2
Nanopore Sequencing for T-Cell Receptor Rearrangement Analysis in Cutaneous T-Cell Lymphoma
Cassandra Cieslak, Carsten Hain, Christian Rückert, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3700-3700
Open Access | Times Cited: 2
Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial
Pablo L. Ortiz‐Romero, Lidia Maroñas Jiménez, Cristina Muniesa, et al.
The Lancet Haematology (2022) Vol. 9, Iss. 6, pp. e425-e433
Closed Access | Times Cited: 11
Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions
Yun‐Tsan Chang, Desislava Ignatova, Wolfram Hoetzenecker, et al.
JID Innovations (2021) Vol. 2, Iss. 1, pp. 100069-100069
Open Access | Times Cited: 13
Time to next treatment and safety assessment in cutaneous-T-cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin
Gabriele Roccuzzo, Paolo Fava, Gianluca Avallone, et al.
British Journal of Dermatology (2022) Vol. 187, Iss. 6, pp. 1019-1021
Open Access | Times Cited: 9
Mechanism of action of chlormethine gel in mycosis fungoides
Emmanuella Guenova, Pablo L. Ortiz‐Romero, Brian Poligone, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 9, pp. 1739-1748
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top